Collection of Hematopoietic Stem Cells after Previous Radioimmunotherapy is Feasible and Does Not Impair Engraftment after Autologous Stem Cell Transplantation in Follicular Lymphoma-Reference-Cited by-同舟云学术

Collection of Hematopoietic Stem Cells after Previous Radioimmunotherapy is Feasible and Does Not Impair Engraftment after Autologous Stem Cell Transplantation in Follicular Lymphoma

Published:2013-12 Issue:12 Volume:19 Page:1695-1701
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Derenzini Enrico,Stefoni Vittorio,Maglie Roberto,Casadei Beatrice,Pellegrini Cinzia,Broccoli Alessandro,Stefani Giulia,Fanti Stefano,Motta Maria Rosa,Narducci Riccardo,Argnani Lisa,Zinzani Pier Luigi

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference39 articles.

1. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project;Anderson;Ann Oncol,1998

2. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001;Morton;Blood,2006

3. How I treat indolent lymphoma;Gribben;Blood,2007

4. New treatment options have changed the survival of patients with follicular lymphoma;Fisher;J Clin Oncol,2005

5. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Yttrium-90 ibritumomab tiuxetan consolidation versus rituximab maintenance therapy after induction chemotherapy in patients with indolent non-Hodgkin lymphoma: a single-institution experience;Hematology;2019-01-01

2. Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma;Immunotherapy;2018-06

3. ASSESSMENT OF FACTORS AFFECTING ENGRAFTMENT AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION;Annals of Clinical and Analytical Medicine;2017

4. Radioimmunotherapy-based conditioning for hematopoietic stem cell transplantation: Another step forward;Blood Reviews;2016-09

5. 90‐yttrium‐ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high‐risk follicular lymphoma: updated long‐term results after a median follow‐up of 7 years;Cancer Medicine;2016-03-14